These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19657322)

  • 1. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.
    Ren S; Babelova A; Moreth K; Xin C; Eberhardt W; Doller A; Pavenstädt H; Schaefer L; Pfeilschifter J; Huwiler A
    Kidney Int; 2009 Oct; 76(8):857-67. PubMed ID: 19657322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β2 (TGF-β2)-induced connective tissue growth factor (CTGF) expression requires sphingosine 1-phosphate receptor 5 (S1P5) in human mesangial cells.
    Wünsche C; Koch A; Goldschmeding R; Schwalm S; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2015 May; 1851(5):519-26. PubMed ID: 25601519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase-1: a potential mediator of renal fibrosis.
    Long DA; Price KL
    Kidney Int; 2009 Oct; 76(8):815-7. PubMed ID: 19789541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
    Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.
    Koch A; Völzke A; Wünsche C; Meyer zu Heringdorf D; Huwiler A; Pfeilschifter J
    Br J Pharmacol; 2012 Jun; 166(3):1018-32. PubMed ID: 22221312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.
    El-Shewy HM; Sohn M; Wilson P; Lee MH; Hammad SM; Luttrell LM; Jaffa AA
    Mol Endocrinol; 2012 May; 26(5):833-45. PubMed ID: 22422617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
    Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
    Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the S1P Transporter Spinster Homology Protein 2 (Spns2) Exerts an Anti-Fibrotic and Anti-Inflammatory Effect in Human Renal Proximal Tubular Epithelial Cells.
    Blanchard O; Stepanovska B; Starck M; Erhardt M; Römer I; Meyer Zu Heringdorf D; Pfeilschifter J; Zangemeister-Wittke U; Huwiler A
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of sphingosine kinase 2 enhances Wilm's tumor suppressor gene 1 and nephrin expression in podocytes and protects from streptozotocin-induced podocytopathy and albuminuria in mice.
    Imeri F; Stepanovska Tanturovska B; Schwalm S; Saha S; Zeng-Brouwers J; Pavenstädt H; Pfeilschifter J; Schaefer L; Huwiler A
    Matrix Biol; 2021 Apr; 98():32-48. PubMed ID: 34015468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway.
    Huang J; Huang K; Lan T; Xie X; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Jan; 365(2):231-40. PubMed ID: 23127801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
    Zhang Y; Li H; Hao J; Zhou Y; Liu W
    Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β(2) , elucidated by treatment with CTGFsiRNA.
    Yang H; Huang Y; Chen X; Liu J; Lu Y; Bu L; Xia L; Xiao W; Chen M; Nie Q; Liu Z
    Acta Ophthalmol; 2010 Sep; 88(6):652-9. PubMed ID: 20039857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.
    Kita T; Hata Y; Kano K; Miura M; Nakao S; Noda Y; Shimokawa H; Ishibashi T
    Diabetes; 2007 Jan; 56(1):231-8. PubMed ID: 17192487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis.
    Kinashi H; Falke LL; Nguyen TQ; Bovenschen N; Aten J; Leask A; Ito Y; Goldschmeding R
    Kidney Int; 2017 Oct; 92(4):850-863. PubMed ID: 28545716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.
    Li SY; Huang PH; Yang AH; Tarng DC; Yang WC; Lin CC; Chen JW; Schmid-Schönbein G; Lin SJ
    Kidney Int; 2014 Aug; 86(2):358-69. PubMed ID: 24670409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous CGRP upregulates profibrogenic growth factors through PKC/JNK signaling pathway in kidney proximal tubular cells.
    Yoon SP; Kim J
    Cell Biol Toxicol; 2018 Aug; 34(4):251-262. PubMed ID: 28540451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.